Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Convergent Imaging Solutions is a private Canadian healthcare software company focused on medical image fusion, nuclear medicine processing, and radiopharmaceutical dosimetry. Its flagship platform, UniSyn MI, supports PET/CT, SPECT/CT, and PET/MR image review, fusion, quantification, and workflow integration for radiology and nuclear medicine users. The company also offers theranostics and molecular radiotherapy dosimetry capabilities, including an FDA 510(k)-cleared dosimetry module. Convergent integrates its software with PACS environments and third-party specialty packages, and its installed base includes hospitals, molecular imaging clinics, radiology groups, and teleradiology providers. The business is best characterized as a commercial-stage medical imaging software vendor rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Convergent Imaging.